Latest Feature Articles
Real-world evidence and clinical research diversity
Research and Development | rweClinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …
MAPs during a global pandemic
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, MAPSEarly and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
How COVID-19 has changed pharmacovigilance
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, pharmacovigilanceThe race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
How COVID-19 has affected the oncology drugs market
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, CancerIn its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
The importance of ethics and patient centricity in managed and early access programmes
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
How COVID-19 is affecting diabetics and their access to insulin in America
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …
How the US election could affect the pharmaceutical industry
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Donald Trump, Joe Biden, Trump, US, US election 2020, pharmaThe US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
Patient Experience: Living with Timothy syndrome
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Timoty syndrome, feature, patient experience, rare diseaseThirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …
Oncology research in the age of COVID-19
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CAR T, CAR-T, Cancer, feature, pharmaMatt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Interview, Working Life, feature“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
CAR T cell therapy is revolutionising cancer treatment, but at what cost?
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | CAR T, CAR-T, Cancer, featureCAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
Is Pharma doing enough on sustainability?
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | antimicrobial resistance, manufacturing, pharma, sustainabilityAdoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
How is COVID-19 impacting the rare disease community?
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, cambridge rare disease network, pharma, rare diseaseThe COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
COVID-19: UK and Europe life sciences regulatory developments
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, Sidley Austin, coronavirus, pharma, regulationMarie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
How digital therapeutics are revolutionising healthcare
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | digital therapeutics, feature, pharmaDigital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
